Beijing Aosaikang Pharmaceutical News

Osecon: Announcement on Subsidiary Nelatinib Maleate Tablets Obtaining a Drug Registration Certificate

Oct 29 12:00 ET

Osecon: Announcement on capital increase for holding subsidiaries

Oct 8 12:00 ET

Osecon: Half-year summary table of non-operating capital usage and other related capital transactions

Aug 29 12:00 ET

Osecon: 2024 semi-annual financial report

Aug 29 12:00 ET

Beijing Aosaikang Pharmaceutical: Announcement regarding the acceptance of the application for the listing permit of the subsidiary's Erlotinib tablets.

Aug 12 12:00 ET

Beijing Aosaikang Pharmaceutical: Announcement regarding subsidiary's pharmaceutical registration certificate for injection of Fosaprepitant Dimeglumine.

Jul 1 12:00 ET

Beijing Aosaikang Pharmaceutical: Legal Opinion on the 2023 Annual General Meeting of Shareholders of Beijing Aosaikang Pharmaceutical Co., Ltd.

May 29 12:00 ET

Beijing Aosaikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 29 12:00 ET

Beijing Aosaikang Pharmaceutical: Announcement on the subsidiary obtaining a drug registration certificate for injectable isaconazole sulfate

May 9 12:00 ET

Beijing Aosaikang Pharmaceutical: Report of the Audit Committee of the Board of Directors on the performance of supervisory duties by accountants in the 2023 annual review

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: 2023 Annual Financial Report

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Board Audit Committee Annual Report Work Procedure (2024)

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Board Remuneration and Assessment Committee Rules of Procedure (2024)

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Notice on amending some clauses of the “Articles of Association”

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Independent Directors' Annual Report Work System (2024)

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: 2023 Financial Results Report

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Internal Control Self-Assessment Report

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Board Audit Committee Rules of Procedure (2024)

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Special Meeting Work System for Independent Directors (2024)

Apr 28 12:00 ET

Beijing Aosaikang Pharmaceutical: Board Nomination Committee Rules of Procedure (2024)

Apr 28 12:00 ET